{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T12:39:50Z","timestamp":1782823190942,"version":"3.54.5"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"DOI":"10.1186\/s12889-025-25073-1","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T10:45:30Z","timestamp":1764153930000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Uptake likelihood assessment of oral cholera vaccine capsules: insights from stakeholder consultations in five countries"],"prefix":"10.1186","volume":"25","author":[{"given":"Dijana","family":"Spasenoska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Lea","family":"Kahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malika","family":"Bouhenia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveena Aloysia","family":"D\u2019Cor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Seok","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Se Eun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,26]]},"reference":[{"key":"25073_CR1","doi-asserted-by":"publisher","unstructured":"Deen J, Mengel MA, Clemens JD. Epidemiology of cholera. Vaccine. 2020;38:A31-A40. https:\/\/doi.org\/10.1016\/j.vaccine.2019.07.078.","DOI":"10.1016\/j.vaccine.2019.07.078"},{"key":"25073_CR2","doi-asserted-by":"publisher","unstructured":"Weill FX, Domman D, Njamkepo E, et al. Genomic history of the seventh pandemic of cholera in Africa. Science (1979). 2017;358(6364):785\u2013789. https:\/\/doi.org\/10.1126\/science.aad5901.","DOI":"10.1126\/science.aad5901"},{"key":"25073_CR3","doi-asserted-by":"publisher","unstructured":"Mutreja A, Kim DW, Thomson NR, et al. Evidence for several waves of global transmission in the seventh cholera pandemic. Nature. 2011;477(7365):462\u2013465. https:\/\/doi.org\/10.1038\/nature10392 .","DOI":"10.1038\/nature10392"},{"key":"25073_CR4","doi-asserted-by":"publisher","unstructured":"Ali M, Nelson AR, Lopez AL, Sack DA. Updated Global Burden of Cholera in Endemic Countries. PLoS Negl Trop Dis. 2015;9(6):e0003832. https:\/\/doi.org\/10.1371\/journal.pntd.0003832 .","DOI":"10.1371\/journal.pntd.0003832"},{"key":"25073_CR5","doi-asserted-by":"publisher","unstructured":"Kanungo S, Azman AS, Ramamurthy T, Deen J, Dutta S. Cholera. Lancet. 2022;399(10333):1429\u20131440. https:\/\/doi.org\/10.1016\/S0140-6736(22)00330-0.","DOI":"10.1016\/S0140-6736(22)00330-0"},{"key":"25073_CR6","doi-asserted-by":"publisher","unstructured":"Mogasale V, Ngogoyo SM, Mogasale V V. Model-based estimation of the economic burden of cholera in Africa. BMJ Open. 2021;11(3):e044615. https:\/\/doi.org\/10.1136\/bmjopen-2020-044615","DOI":"10.1136\/bmjopen-2020-044615"},{"key":"25073_CR7","unstructured":"World Health Organization. Multi-country outbreak of cholera, external situation report #17\u2009\u2212 2024. 2024. https:\/\/www.who.int\/publications\/m\/item\/multi-country-outbreak-of-cholera--external-situation-report--17---15-august-2024. Accessed 4 December 2024."},{"key":"25073_CR8","unstructured":"GTFCC. Global Task Force on Cholera Control Oral Cholera Vaccine. February 24, 2025.\u00a0https:\/\/www.gtfcc.org\/about-cholera\/cholera-situation\/ .\u00a0Accessed 20 June 2025."},{"key":"25073_CR9","unstructured":"World Health Organization. Multi-Country Outbreak of Cholera.; 2025. https:\/\/www.who.int\/publications\/m\/item\/multi-country-outbreak-of-cholera--external-situation-report--26--22-may-2025 .\u00a0Accessed\u00a020 June 2025."},{"key":"25073_CR10","unstructured":"Gavi the VaccineAlliance. Gavi alliance market shaping roadmap for oral cholera vaccines; 2023. https:\/\/www.gavi.org\/sites\/default\/files\/about\/market-shaping\/roadmaps\/Cholera-RM_Public-Summary.pdf. Accessed 3 March 2025."},{"key":"25073_CR11","unstructured":"IVI. IVI begins clinical development of DuoChol oral cholera vaccine.\u00a028 Apr 2023. https:\/\/www.ivi.int\/ivi-begins-clinical-development-of-duochol-oral-cholera-vaccine\/ .\u00a0Accessed 25 Apr 2025."},{"key":"25073_CR12","doi-asserted-by":"publisher","unstructured":"Large K, Ruiz AA, Slovenski I, Vieira M, Moon S. The 30-year evolution of oral cholera vaccines: A case study of a collaborative network alternative innovation model. PLOS Global Public Health. 2025;5(1):e0003599. https:\/\/doi.org\/10.1371\/journal.pgph.0003599","DOI":"10.1371\/journal.pgph.0003599"},{"key":"25073_CR13","unstructured":"European Medicines Agency. Dukoral. April 6, 2022. https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/dukoral.\u00a0Accessed 3 Mar 2025."},{"key":"25073_CR14","unstructured":"Spasenoska D. Tools and platforms that support selection, access, and service strategies. In: 17th TechNet conference: immunization programmes that leave no one behind .2023.\u00a0https:\/\/www.youtube.com\/watch?v=hsdQfBbVtLk&t=2s. Accessed 4 December 2024"},{"key":"25073_CR15","doi-asserted-by":"publisher","unstructured":"Hasso-Agopsowicz M, Spasenoska D, Jansen MPM, et al. Exploring Important Attributes, the Potential Use Cases and Feasibility of Introduction of Measles and Rubella Microarray Patches (MR-MAPs): Insights from Nine Countries. Vaccines (Basel). 2024;12(9):1084. https:\/\/doi.org\/10.3390\/vaccines12091084.","DOI":"10.3390\/vaccines12091084"},{"key":"25073_CR16","doi-asserted-by":"publisher","unstructured":"Kahn AL, Spasenoska D, Ekra KD, et al. Stakeholder Consultation Workshop on the Perceived Value of Thermostable Vaccines to Relieve Program Barriers: A Case Study from C\u00f4te d\u2019Ivoire. Vaccines (Basel). 2024;12(12):1414. https:\/\/doi.org\/10.3390\/vaccines12121414.","DOI":"10.3390\/vaccines12121414"},{"key":"25073_CR17","doi-asserted-by":"publisher","unstructured":"Trolle H, Forsberg B, King C, et al. A scoping review of facilitators and barriers influencing the implementation of surveillance and oral cholera vaccine interventions for cholera control in lower- and middle-income countries. BMC Public Health. 2023;23(1):455. https:\/\/doi.org\/10.1186\/s12889-023-15326-2.","DOI":"10.1186\/s12889-023-15326-2"},{"key":"25073_CR18","doi-asserted-by":"publisher","unstructured":"Bracken L, McDonough E, Ashleigh S, et al. Can children swallow tablets? Outcome data from a feasibility study to assess the acceptability of different-sized placebo tablets in children (creating acceptable tablets (CAT)). BMJ Open. 2020;10(10):e036508. https:\/\/doi.org\/10.1136\/bmjopen-2019-036508","DOI":"10.1136\/bmjopen-2019-036508"},{"key":"25073_CR19","doi-asserted-by":"publisher","unstructured":"Khan AI, Islam MS, Islam MdT, et al. Oral cholera vaccination strategy: Self-administration of the second dose in urban Dhaka, Bangladesh. Vaccine. 2019;37(6):827\u2013832. https:\/\/doi.org\/10.1016\/j.vaccine.2018.12.048 .","DOI":"10.1016\/j.vaccine.2018.12.048"},{"key":"25073_CR20","doi-asserted-by":"publisher","unstructured":"Heyerdahl LW, Ngwira B, Demolis R, et al. Innovative vaccine delivery strategies in response to a cholera outbreak in the challenging context of Lake Chilwa. A rapid qualitative assessment. Vaccine. 2018;36(44):6491\u20136496. https:\/\/doi.org\/10.1016\/j.vaccine.2017.10.108 .","DOI":"10.1016\/j.vaccine.2017.10.108"},{"key":"25073_CR21","doi-asserted-by":"publisher","unstructured":"Grandesso F, Rafael F, Chipeta S, et al. Oral cholera vaccination in hard-to-reach communities, Lake Chilwa, Malawi. Bull World Health Organ. 2018;96(12):817\u2013825. https:\/\/doi.org\/10.2471\/BLT.17.206417 .","DOI":"10.2471\/BLT.17.206417"},{"key":"25073_CR22","doi-asserted-by":"publisher","unstructured":"Giersing B, Shah N, Kristensen D, et al. Strategies for vaccine-product innovation: Creating an enabling environment for product development to uptake in low- and middle-income countries. Vaccine. 2021;39(49):7208\u20137219. https:\/\/doi.org\/10.1016\/j.vaccine.2021.07.091","DOI":"10.1016\/j.vaccine.2021.07.091"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-25073-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-025-25073-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-25073-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T10:45:31Z","timestamp":1764153931000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-025-25073-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["25073"],"URL":"https:\/\/doi.org\/10.1186\/s12889-025-25073-1","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,26]]},"assertion":[{"value":"14 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The generic study protocol detailing the approach used for the workshops has been exempted by the WHO Research Ethics Review Committee (ERC) from requiring ethical review and clearance on the basis of the participating public officials being interviewed in their official, professional capacity on issues that are in the public domain.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"<!--Emphasis Type='Bold' removed-->Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4147"}}